RADIATION THERAPY ONCOLOGY GROUP
RTOG 0712
A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Flourouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy
RTOG 0712
A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Flourouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy
Protocol Participation Information
- Credentialing
- Credentialing Requirements
- Facility Questionnaire
- Download Forms (Part I only)
- Submit to RTOG
- How to Participate
- Digital Data Submission Procedures
- Digital Data Submission Information (DDSI) Form
- Data Submission Checklist
- ATC Compliant Treatment Planning Systems
- Structure Names
- Protocol Text (http://www.rtog.org/)
Back to protocols
